Abdel‐Baset Halim

1.0k total citations
14 papers, 388 citations indexed

About

Abdel‐Baset Halim is a scholar working on Molecular Biology, Rheumatology and Oncology. According to data from OpenAlex, Abdel‐Baset Halim has authored 14 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Rheumatology and 3 papers in Oncology. Recurrent topics in Abdel‐Baset Halim's work include Folate and B Vitamins Research (3 papers), Fibroblast Growth Factor Research (2 papers) and Atrial Fibrillation Management and Outcomes (2 papers). Abdel‐Baset Halim is often cited by papers focused on Folate and B Vitamins Research (3 papers), Fibroblast Growth Factor Research (2 papers) and Atrial Fibrillation Management and Outcomes (2 papers). Abdel‐Baset Halim collaborates with scholars based in United States, France and United Kingdom. Abdel‐Baset Halim's co-authors include Malak Kotb, Arthur M. Geller, Hélène Legros, Leighton LeGros, Margaret E. Chamberlin, Michael A. Gerber, S. Dash, Robert F. Garry, Shahana Urooj Kazmi and Ramy K. Aziz and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Annals of the New York Academy of Sciences.

In The Last Decade

Abdel‐Baset Halim

14 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abdel‐Baset Halim United States 10 159 74 70 64 54 14 388
HH Peter Germany 12 36 0.2× 28 0.4× 59 0.8× 16 0.3× 24 0.4× 22 414
Joseph J. Goswitz United States 12 170 1.1× 41 0.6× 23 0.3× 72 1.1× 65 1.2× 22 530
Kirsten Ebbert Canada 4 58 0.4× 9 0.1× 33 0.5× 16 0.3× 53 1.0× 7 410
S Yasuoka Japan 9 69 0.4× 22 0.3× 15 0.2× 34 0.5× 37 0.7× 24 371
Pamela Stein Germany 14 86 0.5× 110 1.5× 27 0.4× 57 0.9× 40 0.7× 19 506
Eriko Yamada Japan 12 65 0.4× 37 0.5× 19 0.3× 17 0.3× 41 0.8× 19 554
Nancy Freitag Germany 18 163 1.0× 30 0.4× 99 1.4× 16 0.3× 33 0.6× 32 808
Wenqian Zhang China 13 176 1.1× 10 0.1× 17 0.2× 26 0.4× 88 1.6× 28 451
R Niehues Germany 7 253 1.6× 26 0.4× 36 0.5× 30 0.5× 9 0.2× 18 522
Zahedi Mujawar United States 6 158 1.0× 27 0.4× 13 0.2× 136 2.1× 67 1.2× 7 562

Countries citing papers authored by Abdel‐Baset Halim

Since Specialization
Citations

This map shows the geographic impact of Abdel‐Baset Halim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdel‐Baset Halim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdel‐Baset Halim more than expected).

Fields of papers citing papers by Abdel‐Baset Halim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdel‐Baset Halim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdel‐Baset Halim. The network helps show where Abdel‐Baset Halim may publish in the future.

Co-authorship network of co-authors of Abdel‐Baset Halim

This figure shows the co-authorship network connecting the top 25 collaborators of Abdel‐Baset Halim. A scholar is included among the top collaborators of Abdel‐Baset Halim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdel‐Baset Halim. Abdel‐Baset Halim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Goyal, Lipika, Daniel DiToro, Antoine Hollebecque, et al.. (2024). Genomic correlates of response and resistance to the irreversible FGFR1-4 inhibitor futibatinib based on biopsy and circulating tumor DNA profiling. Annals of Oncology. 36(4). 414–425. 2 indexed citations
2.
DiPeri, Timothy P., Ming Zhao, Kurt W. Evans, et al.. (2023). Convergent MAPK pathway alterations mediate acquired resistance to FGFR inhibitors in FGFR2 fusion-positive cholangiocarcinoma. Journal of Hepatology. 80(2). 322–334. 18 indexed citations
3.
Rodón, Jordi, Pauline Funchain, Theodore W. Laetsch, et al.. (2022). A phase II Study of TAS-117 in Patients with Advanced Solid Tumors Harboring Germline PTEN -Inactivating Mutations. Future Oncology. 18(30). 3377–3387. 12 indexed citations
4.
Vahdat, Linda T., Peter Schmid, Andres Forero‐Torres, et al.. (2021). Glembatumumab vedotin for patients with metastatic, gpNMB overexpressing, triple-negative breast cancer (“METRIC”): a randomized multicenter study. npj Breast Cancer. 7(1). 57–57. 39 indexed citations
5.
Halim, Abdel‐Baset. (2018). Do We have a Satisfactory Cell Viability Assay? Review of the Currently Commercially-Available Assays. Current Drug Discovery Technologies. 17(1). 2–22. 21 indexed citations
6.
Halim, Abdel‐Baset. (2015). Some imminent but overlooked preanalytical and analytical challenges currently facing biomarkers and companion diagnostics. Annals of the New York Academy of Sciences. 1346(1). 63–70. 2 indexed citations
7.
Matsushima, Nobuko, Abdel‐Baset Halim, Ling He, et al.. (2012). Edoxaban administration following enoxaparin: A pharmacodynamic, pharmacokinetic, and tolerability assessment in human subjects. Thrombosis and Haemostasis. 108(7). 166–175. 33 indexed citations
8.
Halim, Abdel‐Baset, Yan Li, Evan A. Stein, & Jeanne Mendell. (2011). Low Concentrations of rhFVIIa or FEIBA Significantly and Rapidly Reverse the Anticoagulant Effects of Supratherapeutic Edoxaban. Blood. 118(21). 1252–1252. 6 indexed citations
9.
Halim, Abdel‐Baset, Leighton LeGros, Margaret E. Chamberlin, Arthur M. Geller, & Malak Kotb. (2001). Regulation of the Human MAT2A Gene Encoding the Catalytic α2 Subunit of Methionine Adenosyltransferase, MAT II. Journal of Biological Chemistry. 276(13). 9784–9791. 24 indexed citations
10.
LeGros, Leighton, Abdel‐Baset Halim, Margaret E. Chamberlin, Arthur M. Geller, & Malak Kotb. (2001). Regulation of the Human MAT2B Gene Encoding the Regulatory β Subunit of Methionine Adenosyltransferase, MAT II. Journal of Biological Chemistry. 276(27). 24918–24924. 48 indexed citations
11.
Kazmi, Shahana Urooj, Rita G. Kansal, Ramy K. Aziz, et al.. (2001). Reciprocal, Temporal Expression of SpeA and SpeB by Invasive M1T1 Group A Streptococcal Isolates In Vivo. Infection and Immunity. 69(8). 4988–4995. 71 indexed citations
12.
Legros, Hélène, Abdel‐Baset Halim, Arthur M. Geller, & Malak Kotb. (2000). Cloning, Expression, and Functional Characterization of the β Regulatory Subunit of Human Methionine Adenosyltransferase (MAT II). Journal of Biological Chemistry. 275(4). 2359–2366. 70 indexed citations
13.
Halim, Abdel‐Baset, Robert F. Garry, S. Dash, & Michael A. Gerber. (1999). Effect of schistosomiasis and hepatitis on liver disease.. American Journal of Tropical Medicine and Hygiene. 60(6). 915–920. 40 indexed citations
14.
Halim, Abdel‐Baset, et al.. (1986). Cell Surface Antigen in Bilharzial Bladder Tumours. British Journal of Urology. 58(5). 523–525. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026